Men over 40 with BRCA2 gene fault ‘should get regular PSA screening’ 05 Nov 2019 Guidelines should change so that all men over the age of 40 with faults in the BRCA2 gene should be offered regular PSA testing to detect early signs of prostate cancer, experts are urging. Find out more Show/Hide
Increased risk of prostate cancer in men with BRCA2 gene fault 17 Sep 2019 Men with faults in the BRCA2 gene have an increased risk of prostate cancer and could benefit from PSA testing to help detect the disease earlier, according to new research. Find out more Show/Hide
ASCO 2019: Breast cancer drug effective in 80 per cent of men with BRCA-mutant prostate cancer 05 Jun 2019 A pioneering gene-targeted drug already licensed for breast and ovarian cancer can benefit some men with prostate cancer, a major new clinical trial reports. Find out more Show/Hide
The ICR responds to the FDA approval of talazoparib for women with BRCA-mutant advanced breast cancer 18 Oct 2018
The ICR responds to the FDA approval of olaparib for women with BRCA-mutant advanced breast cancer 12 Jan 2018